Navigation Links
Orexigen Therapeutics to Present at Upcoming Investor Conferences
Date:2/7/2013

SAN DIEGO, Feb. 7, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:The 15th Annual BIO CEO & Investor Conference Date:

Tuesday, February 12, 2013Time:

2:00 p.m. Eastern TimeLocation:

The Waldorf Astoria, New York2013 Leerink Swann Global Healthcare Conference Date:

Wednesday, February 13, 2013Time:

11:30 a.m. Eastern Time Location:

The Waldorf Astoria, New YorkThe BIO CEO & Investor Conference presentation will be webcast live. To access the webcast, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Orexigen Contact: McDavid Stilwell
VP, Corporate Communications and Business Development 
(858) 875-8629

Media Contact: Denise Powell
BrewLife
(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2020)... ... ... By Heidi Jean Doerfert , During this unprecedented time when the world has ... is going full speed ahead. Founders Cynthia and Thane Murphy have brought on ... wet in marketing, social media content, research, data analysis and human resources for the ...
(Date:7/2/2020)... ... ... Exercise.com, the fitness industry’s leading tech company specializing in all-in-one business software ... software during the months of May and June. This announcement highlights the growing demand ... gym giants like 24 Hour Fitness and Gold’s Gym are ...
(Date:7/2/2020)... ... July 02, 2020 , ... Realty ONE Group ... health series on its live agent Town Halls, furthering its commitment to its ... series includes special guests and Realty ONE Group leadership discussing social, mental, physical ...
Breaking Medicine Technology:
(Date:6/28/2020)... ... June 26, 2020 , ... ... to provide high-quality, intensive education and training that prepares graduates for professional careers ... new member of the Board of Trustees. , Ms. Williams currently serves as ...
(Date:6/28/2020)... ... , ... The secret of surviving a pandemic with one’s sanity intact does ... it was the first product to disappear off the shelves when the COVID-19 crisis ... the less need to venture out, the longer you can “survive”. However, does all ...
(Date:6/25/2020)... ANNAPOLIS, Md. (PRWEB) , ... June 25, 2020 , ... ... and treating providers on the key steps when filing appeals for denials of mental ... insurance experts to help educate individuals about their appeal rights and explain the steps ...
(Date:6/24/2020)... ... June 24, 2020 , ... ... announced that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ ... the framework of value-based care. Use of Population Care is benefitting more than ...
(Date:6/23/2020)... ... June 23, 2020 , ... Oak Street Health, a ... announced further plans for nationwide expansion in 2020 with the company’s first centers in ... open two locations in Brooklyn, N.Y., and a new center in Jackson, Miss. ...
Breaking Medicine News(10 mins):